M5c-Methylated Lncrna NR_033928 Promotes Gastric Cancer Proliferation by Stabilizing GLS Mrna to Promote Glutamine Metabolism Reprogramming

Lang Fang,Hongxin Huang,Jialun Lv,Zetian Chen,Chen Lu,Tianlu Jiang,Penghui Xu,Ying Li,Sen Wang,Bowen Li,Zheng Li,Weizhi Wang,Zekuan Xu
DOI: https://doi.org/10.1038/s41419-023-06049-8
2023-01-01
Cell Death and Disease
Abstract:Abnormal 5-methylcytosine (m5C) methylation has been proved to be closely related to gastric carcinogenesis, progression, and prognosis. Dysregulated long noncoding RNAs (lncRNAs) participate in a variety of biological processes in cancer. However, to date, m5C-methylated lncRNAs are rarely researched in gastric cancer (GC). Here, we found that RNA cytosine-C(5)-methyltransferase (NSUN2) was upregulated in GC and high NSUN2 expression was associated with poor prognosis. NR_033928 was identified as an NSUN2-methylated and upregulated lncRNA in GC. Functionally, NR_033928 upregulated the expression of glutaminase (GLS) by interacting with IGF2BP3/HUR complex to promote GLS mRNA stability. Increased glutamine metabolite, α-KG, upregulated NR_033928 expression by enhancing its promoter 5-hydroxymethylcytosine (hm5C) demethylation. In conclusion, our results revealed that NSUN2-methylated NR_033928 promoted GC progression and might be a potential prognostic and therapeutic target for GC.
What problem does this paper attempt to address?